Quantcast
Skip to main content
Environmental Health Perspectives Podcasts - The Researcher's Perspectives
Full
About EHP Publications Past Issues News By Topic Authors Subscribe Press International Inside EHP Email Alerts spacer
Environmental Health Perspectives (EHP) is a monthly journal of peer-reviewed research and news on the impact of the environment on human health. EHP is published by the National Institute of Environmental Health Sciences and its content is free online. Print issues are available by paid subscription.DISCLAIMER
spacer
NIEHS
NIH
DHHS
spacer
Current Issue

EHP Science Education Website




EHP on Twitter

AAAR

Comparative Toxicogenomics Database (CTD)

spacer
Environmental Health Perspectives Volume 114, Number 11, November 2006 Open Access
spacer
Biomarkers of Exposure: A Case Study with Inorganic Arsenic

Michael F. Hughes

National Health and Environmental Effects Research Laboratory, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina, USA

Abstract
The environmental contaminant inorganic arsenic (iAs) is a human toxicant and carcinogen. Most mammals metabolize iAs by reducing it to trivalency, followed by oxidative methylation to pentavalency. iAs and its methylated metabolites are primarily excreted in urine within 4–5 days by most species and have a relatively low rate of bioaccumulation. Intra- and interindividual differences in the methylation of iAs may affect the adverse health effects of arsenic. Both inorganic and organic trivalent arsenicals are more potent toxicants than pentavalent forms. Several mechanisms of action have been proposed for arsenic-induced toxicity, but a scientific consensus has not been achieved. Biomarkers of exposure may be used to quantify exposure to iAs. The most common biomarker of exposure for iAs is the measurement of total urinary arsenic. However, consumption of seafood containing high concentrations of organic arsenic can confound estimation of iAs exposure. Because these organic species are thought to be relatively nontoxic, their presence in urine may not represent increased risk. Speciation of urinary arsenic into inorganic and organic forms, and even oxidation state, gives a more definitive indication of the exposure to iAs. Questions still remain, however, as to how reliably the measurement of urinary arsenic, either total or speciated, may predict arsenic concentrations at target tissues as well as how this measurement could be used to assess chronic exposures to iAs. Key words: , , , , . Environ Health Perspect 14:1790–1796 (2006) . [Online 12 June 2006]


This article is part of the mini-monograph "Use of Biomonitoring Data in Exposure and Human Health Risk Assessments."

Address correspondence to M.F. Hughes, U.S. EPA, MD B143-01, Research Triangle Park, NC 27711 USA. Telephone: (919) 541-2160. Fax: (919) 541-4284. E-mail: hughes.michaelf@epa.gov

I thank L. Birnbaum, E. Faustman, J. Mumford, S. Robison, D. Thomas, and K. Thomas for their helpful comments.

This article has been reviewed in accordance with the policy of the National Health and Environmental Effects Research Laboratory, U.S. EPA, and approved for publication. Approval does not signify that the contents necessarily reflect the views and policies of the agency, nor does mention of trade names or commercial products constitute endorsement or recommendation for use.

The author declares he has no competing financial interest.

Received 1 February 2006 ; accepted 10 May 2006.


The full version of this article is available for free in HTML or PDF formats.
spacer
 
Open Access Resources | Call for Papers | Career Opportunities | Buy EHP Publications | Advertising Information | Subscribe to the EHP News Feeds News Feeds | Inspector General USA.gov

Download Adobe Acrobat Reader to view PDF files located on this site.